LIBERTY DEFENSE HOLDINGS LTD (SCAN.CA) Stock Fundamental Analysis

TSX-V:SCAN • CA53044R8839

0.17 CAD
0 (0%)
Last: Feb 26, 2026, 07:00 PM
Fundamental Rating

0

Taking everything into account, SCAN scores 0 out of 10 in our fundamental rating. SCAN was compared to 25 industry peers in the Commercial Services & Supplies industry. SCAN has a bad profitability rating. Also its financial health evaluation is rather negative. SCAN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • SCAN had negative earnings in the past year.
  • In the past year SCAN has reported a negative cash flow from operations.
  • In the past 5 years SCAN always reported negative net income.
  • In the past 5 years SCAN always reported negative operating cash flow.
SCAN.CA Yearly Net Income VS EBIT VS OCF VS FCFSCAN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

  • SCAN's Return On Assets of -127.78% is on the low side compared to the rest of the industry. SCAN is outperformed by 88.00% of its industry peers.
Industry RankSector Rank
ROA -127.78%
ROE N/A
ROIC N/A
ROA(3y)-159.03%
ROA(5y)-143.68%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SCAN.CA Yearly ROA, ROE, ROICSCAN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for SCAN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SCAN.CA Yearly Profit, Operating, Gross MarginsSCAN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600

0

2. Health

2.1 Basic Checks

  • SCAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, SCAN has more shares outstanding
  • SCAN has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, SCAN has a worse debt to assets ratio.
SCAN.CA Yearly Shares OutstandingSCAN.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SCAN.CA Yearly Total Debt VS Total AssetsSCAN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

  • Based on the Altman-Z score of -13.28, we must say that SCAN is in the distress zone and has some risk of bankruptcy.
  • SCAN has a Altman-Z score of -13.28. This is amonst the worse of the industry: SCAN underperforms 88.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -13.28
ROIC/WACCN/A
WACC10.88%
SCAN.CA Yearly LT Debt VS Equity VS FCFSCAN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M

2.3 Liquidity

  • SCAN has a Current Ratio of 0.50. This is a bad value and indicates that SCAN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • SCAN's Current ratio of 0.50 is on the low side compared to the rest of the industry. SCAN is outperformed by 80.00% of its industry peers.
  • A Quick Ratio of 0.37 indicates that SCAN may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.37, SCAN is doing worse than 80.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.5
Quick Ratio 0.37
SCAN.CA Yearly Current Assets VS Current LiabilitesSCAN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

1

3. Growth

3.1 Past

  • SCAN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.49%, which is quite impressive.
  • SCAN shows a strong growth in Revenue. In the last year, the Revenue has grown by 63.38%.
EPS 1Y (TTM)29.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.72%
Revenue 1Y (TTM)63.38%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-66.51%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SCAN.CA Yearly Revenue VS EstimatesSCAN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 500K 1M 1.5M 2M
SCAN.CA Yearly EPS VS EstimatesSCAN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 -2 -4 -6 -8

0

4. Valuation

4.1 Price/Earnings Ratio

  • SCAN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SCAN.CA Price Earnings VS Forward Price EarningsSCAN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SCAN.CA Per share dataSCAN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for SCAN!.
Industry RankSector Rank
Dividend Yield 0%

LIBERTY DEFENSE HOLDINGS LTD

TSX-V:SCAN (2/26/2026, 7:00:00 PM)

0.17

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)11-26
Earnings (Next)04-23
Inst Owners5.46%
Inst Owner ChangeN/A
Ins Owners1.25%
Ins Owner ChangeN/A
Market Cap15.18M
Revenue(TTM)2.44M
Net Income(TTM)-8.85M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.55
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.7
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0.04
BVpS-0.02
TBVpS-0.05
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -127.78%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-159.03%
ROA(5y)-143.68%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 28.62%
Cap/Sales 10.59%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.5
Quick Ratio 0.37
Altman-Z -13.28
F-Score4
WACC10.88%
ROIC/WACCN/A
Cap/Depr(3y)44.5%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.72%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)63.38%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-66.51%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y18.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-83.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-87.6%
OCF growth 3YN/A
OCF growth 5YN/A

LIBERTY DEFENSE HOLDINGS LTD / SCAN.CA FAQ

What is the fundamental rating for SCAN stock?

ChartMill assigns a fundamental rating of 0 / 10 to SCAN.CA.


What is the valuation status for SCAN stock?

ChartMill assigns a valuation rating of 0 / 10 to LIBERTY DEFENSE HOLDINGS LTD (SCAN.CA). This can be considered as Overvalued.


How profitable is LIBERTY DEFENSE HOLDINGS LTD (SCAN.CA) stock?

LIBERTY DEFENSE HOLDINGS LTD (SCAN.CA) has a profitability rating of 0 / 10.


What is the financial health of LIBERTY DEFENSE HOLDINGS LTD (SCAN.CA) stock?

The financial health rating of LIBERTY DEFENSE HOLDINGS LTD (SCAN.CA) is 0 / 10.